Australia Accepts US FDA 510(k) for Class III & IIa Devices
On 16 October, an amendment to Australian legislation was published that expands the conditions for medical devices already marketed in…
Stay informed with real-time regulatory news and expert insights, and keep the conversation going by connecting with us on social media.
Showing 127–135 of 229
On 16 October, an amendment to Australian legislation was published that expands the conditions for medical devices already marketed in…
The FDA issued draft guidance on September 19, 2024, concerning its recommendations related to chemical analysis for biocompatibility assessment of…
Currently the FDA recognizes 100’s of consensus standards from reputable organizations such as ISO, ANSI, AAMI, IEC, ASTM, etc. These…
The final rule related to medical devices and LDTs (Laboratory Developed Tests) was finalized in April 2024 by the FDA.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has introduced the first significant update to…
User guides have been updated to include the transition eligibility content. While custom made devices are now exempt from requirement…
The MDCG 2021-25 (Rev1.0) has been updated, reflecting the latest developments in the MDCG MDR Transition. The guidance now takes…
The inspections conducted by the Healthcare and Youth Care Inspectorate (IGJ), based in the Netherlands, focused on evaluating manufacturers’ adherence to Post-Market…
The decommissioning of 3G networks in favor of more advanced 4G and 5G networks may affect medical devices and products…
Showing 127–135 of 229